Skip to main content
. 2024 Sep 5;29:118. doi: 10.1186/s11658-024-00627-0

Fig. 3.

Fig. 3

Hsa_circ_0000520 binds to Lin28a and reduces its protein stability. A RNA pulldown product validation by WB confirms the pulldown of Lin28a by hsa_circ_0000520. B RIP reverse analysis demonstrates the binding between Lin28a and hsa_circ_0000520. C Fluorescence colocalization analysis reveals the co-localization of hsa_circ_0000520 with Lin28a. D, E qRT-PCR analysis of the impact of overexpression and knockdown of hsa_circ_0000520 on Lin28a mRNA levels. F, G WB analysis of the effect of overexpression and knockdown of hsa_circ_0000520 on Lin28a protein levels. H WB analysis of changes in Lin28a protein levels after streptavidin treatment in the overexpression group of hsa_circ_0000520. I WB analysis of changes in Lin28a protein levels after streptavidin treatment in the knockdown group of hsa_circ_0000520. J WB analysis of changes in Lin28a protein levels after MG132 treatment in the overexpression group of hsa_circ_0000520. K WB analysis of changes in Lin28a protein levels after MG132 treatment in the knockdown group of hsa_circ_0000520. L Co-IP analysis of changes in Lin28a ubiquitination levels after MG132 treatment in the overexpression group of hsa_circ_0000520. M Co-IP analysis of changes in Lin28a ubiquitination levels after MG132 treatment in the knockdown group of hsa_circ_0000520. β-actin serves as an internal reference. *P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001